abstract |
In the present invention, compounds such as (1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N- (5-Fluoropyridin-2-yl)cyclopropanecarboxamide has been found to be a potent orexin receptor antagonist and is useful in the treatment of sleep disorders such as insomnia, among other therapeutic uses. |